Compare CTXR & JF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CTXR | JF |
|---|---|---|
| Founded | 2007 | 2012 |
| Country | United States | China |
| Employees | N/A | 78 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.9M | 16.2M |
| IPO Year | 2010 | N/A |
| Metric | CTXR | JF |
|---|---|---|
| Price | $0.65 | $1.08 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 696.7K | 13.3K |
| Earning Date | 05-13-2026 | 04-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 43.38 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $147.57 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.63 | $0.89 |
| 52 Week High | $2.38 | $1.12 |
| Indicator | CTXR | JF |
|---|---|---|
| Relative Strength Index (RSI) | 37.33 | 64.61 |
| Support Level | N/A | $0.90 |
| Resistance Level | $0.98 | N/A |
| Average True Range (ATR) | 0.07 | 0.07 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 5.97 | 91.97 |
Citius Pharmaceuticals Inc is a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, with a focus on oncology, anti-infectives in adjunct cancer care and distinct prescription products. It aims to provide therapeutic products that address unmet medical needs yet have a lower development risk than is usually associated with new chemical entities. The company's flagship product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein. It operates through a single operating and reportable segment which is focused on developing and commercializing pioneering targeted oncology therapies.
J and Friends Holdings Ltd, formerly Pintec Technology Holdings Ltd is a technology platform that provides financial services in China in terms of loan volume facilitated. The company connects business partners and financial partners on its open platform and enables them to provide financial services to end-users. Its products include installment loans, personal loans, wealth management, insurance brokerage, SME loans, and others. The company generates its revenue from technical service fees, as well as by providing financing for these borrowers and earning installment service fees. The company earns wealth management services fees and commissions on financial products. The company generates the majority of its revenue from Wealth management service fees and others.